METABOLISM OF ALDRIN TO DIELDRIN BY RAT SKIN FOLLOWING TOPICAL APPLICATION

被引:9
作者
GRAHAM, MJ [1 ]
WILLIAMS, FM [1 ]
RAWLINS, MD [1 ]
机构
[1] UNIV NEWCASTLE UPON TYNE,WOLFSON UNIT CLIN PHARMACOL,NEWCASTLE TYNE NE1 7RU,TYNE & WEAR,ENGLAND
关键词
D O I
10.1016/0278-6915(91)90129-U
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Metabolism of the pesticide aldrin to dieldrin in the rat was studied following topical and ip administration of 0.1-10 mg aldrin/kg body weight. When aldrin was applied topically to the dorsal skin at a dose of 10 mg/kg body weight, absorption was less efficient than after ip administration; lower blood levels of aldrin and dieldrin were seen and peak dieldrin levels were delayed. After ip administration of 1 or 10 mg aldrin/kg body weight, dieldrin was found at similar concentrations in the dorsal and ventral skin 7 hr later, whereas 7 hr after topical administration of 10 mg aldrin/kg, the dieldrin concentration in the skin at the dorsal site of application was four times higher than that at a ventral skin site. Similar differences in dieldrin concentrations between dorsal and ventral skin persisted throughout the 7-hr period following topical application. The results indicate that topically applied aldrin is metabolized to dieldrin in the skin during absorption, but the overall proportion of metabolism that takes place in the skin is small compared with the contribution of the liver. Dieldrin was not detected in the ventral skin remote from the application site 1 hr after topical application of aldrin, whereas a dieldrin concentration of 2.2 nmol/g was detected in the skin of the application site at this time; more than 99% of this dieldrin was probably formed locally by dermal metabolism of percutaneously absorbed aldrin. The efficiency of conversion of applied aldrin to dieldrin decreased with increasing aldrin dose in the range 0.1 to 10 mg/kg.
引用
收藏
页码:707 / 711
页数:5
相关论文
共 15 条
[1]  
BICKERS DR, 1980, EXTRAHEPATIC METABOL, P295
[2]   EXTENT OF CUTANEOUS METABOLISM DURING PERCUTANEOUS-ABSORPTION OF XENOBIOTICS [J].
BRONAUGH, RL ;
STEWART, RF ;
STORM, JE .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1989, 99 (03) :534-543
[3]  
GRAHAM MJ, 1987, PHARM SKIN, V1, P252
[4]   COMPARISON OF HYDROCARBON DNA ADDUCTS FORMED IN MOUSE SKIN INVIVO AND IN ORGAN-CULTURE INVITRO FOLLOWING TREATMENT WITH BENZO[A]PYRENE [J].
HUCKLE, KR ;
SMITH, RJ ;
WATSON, WP ;
WRIGHT, AS .
CARCINOGENESIS, 1986, 7 (06) :965-970
[5]   SKIN PENETRATION AND METABOLISM OF TOPICALLY APPLIED CHEMICALS IN 6 MAMMALIAN-SPECIES, INCLUDING MAN - AN INVITRO STUDY WITH BENZO[A]PYRENE AND TESTOSTERONE [J].
KAO, J ;
PATTERSON, FK ;
HALL, J .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1985, 81 (03) :502-516
[6]  
KAPPUS H, 1989, PHARM SKIN, V2
[7]  
MACPHERSON SE, 1990, PREDICTION OF PERCUTANEOUS PENETRATION, P135
[8]   PRE-SYSTEMIC METABOLISM OF VIPROSTOL IN THE MONKEY FOLLOWING ORAL AND TOPICAL ADMINISTRATION [J].
NICOLAU, G ;
TONELLI, AP ;
COSULICH, DB ;
PERKINSON, NA ;
DICIOCCIO, AT ;
MCWILLIAMS, WE ;
YACOBI, A .
XENOBIOTICA, 1988, 18 (07) :797-802
[9]   SUBSTRATE-SPECIFICITY OF THE MOUSE SKIN MIXED-FUNCTION OXIDASE SYSTEM [J].
RETTIE, AE ;
WILLIAMS, FM ;
RAWLINS, MD .
XENOBIOTICA, 1986, 16 (03) :205-211
[10]  
SCOTT RC, 1989, PHARM SKIN, V2